Michael Keese | Medicine | Best Review Article Award

Posted on by ScienceFather

Assoc. Prof. Dr. Michael Keese | Medicine | Best Review Article Award 

Assoc. Prof. Dr. Michael Keese, TKH Mannheim, Germany

Assoc. Prof. Dr. Michael Keese is a distinguished researcher and educator at TKH Mannheim, Germany. He earned his doctorate (summa cum laude) in 1998 from the Biochemical Institute 2 at the University of Heidelberg. Following a decade of research and teaching at the University Medical Center Mannheim (UMM), he completed his habilitation. In 2013, he re-habilitated at the Medical Faculty of Goethe University Frankfurt and was appointed as an extraordinary professor in 2015. He rejoined UMM Mannheim in 2017 while continuing his teaching at the University Hospital Frankfurt. In 2023, he was appointed as a Visiting Professor at Baku State University, Azerbaijan.

Education:

Doctorate (PhD): Biochemical Institute 2, University of Heidelberg, Germany (1998) – Summa cum laude

Habilitation: University Medical Center Mannheim (UMM), Germany (after 10 years of research and teaching)

Re-habilitation: Medical Faculty, Goethe University Frankfurt, Germany (2013)

Professional Profiles:

ORCID Profile

Professional Experience:

Director, Department of Vascular and Endovascular Surgery, Theresienkrankenhaus and Diako Mannheim (since April 2022)

Visiting Professor, Baku State University, Azerbaijan (since November 2023)

Editor, Journal of Clinical Medicine (JCM) (since February 2023)

Head of Vascular Surgery, Universitätsmedizin Mannheim (2017–2022)

Head of Transplant Surgery, Universitätsmedizin Mannheim (2018–2022)

Deputy Clinic Director & Chief Senior Physician, Department of Vascular and Endovascular Surgery, Johann Wolfgang Goethe University Frankfurt (2015–2017)

Senior Physician & Head of Endovascular Surgery, Department of Vascular and Endovascular Surgery, Johann Wolfgang Goethe University Frankfurt (2011–2015)

Deputy Head, Vascular Surgery Section, Universitätsmedizin Mannheim (2010–2011)

Senior Physician, Department of Surgery, Universitätsmedizin Mannheim (2010–2011)

Specialist in Vascular Surgery, Universitätsmedizin Mannheim (2010)

Assistant Physician & Specialist in Surgery, Universitätsmedizin Mannheim (2004–2010)

Assistant Physician, Department of Surgery, Universitätsmedizin Mannheim (1999–2003)

Postdoctoral Researcher, EMBL Heidelberg (2003–2004)

Research Interests:

Establishment of novel imaging models for monitoring receptor tyrosine kinases

Contributions to the cell biology of mesenchymal stem cells, particularly their influence on vascular muscle cells and human umbilical vein endothelial cells (HUVECs)

siRNA and microRNA profiling of vascular smooth muscle cells (VSMCs) and endothelial cells

Top Notable Publications:

The Differentiation and Regeneration Potential of ABCB5+ Mesenchymal Stem Cells: A Review and Clinical Perspectives

Journal: Journal of Clinical Medicine

Date: 2025-01-21

DOI: 10.3390/jcm14030660

Contributors: Zheng He, Vytaute Starkuviene, Michael Keese

2. MTHFR Gene C677T Polymorphism (rs1801133) and Susceptibility to Colorectal Polyps in an Azerbaijani Population

Journal: Journal of Clinical Medicine

Date: 2023-12-30

DOI: 10.3390/jcm13010219

Contributors: Hazi Aslanov, Bayram Bayramov, Christoph Reissfelder, Shams Abdullayeva, Zeynab Mammadova, Fikrat Aliyev, Michael Keese, Javahir Hajibabazade, Vugar Yagublu

3. Adipose-Derived Mesenchymal Stem Cells Protect Endothelial Cells from Hypoxic Injury by Suppressing Terminal UPR In Vivo and In Vitro

Journal: International Journal of Molecular Sciences

Date: 2023-12-06

DOI: 10.3390/ijms242417197

Contributors: Michael Keese, Jiaxing Zheng, Kaixuan Yan, Karen Bieback, Benito A. Yard, Prama Pallavi, Christoph Reissfelder, Mark Andreas Kluth, Martin Sigl, Vugar Yagublu

4. A Systematic Review and Bayesian Network Meta-Analysis on the Effect of Different Anticoagulants on the Prophylaxis of Post-Thrombotic Syndrome after Deep Venous Thrombosis

Journal: Journal of Clinical Medicine

Date: 2023-11-30

DOI: 10.3390/jcm12237450

Contributors: Jingbo Shao, Qianwen Zhou, Fukang Jin, Christoph Reissfelder, Martin Sigl, Vugar Yagublu, Michael Keese

5. Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines

Journal: International Journal of Molecular Sciences

Date: 2023-08

DOI: 10.3390/ijms241713530

Contributors: Feng Guo, Kejia Kan, Felix Rückert, Wolfgang Rückert, Lin Li, Johannes Eberhard, Tobias May, Carsten Sticht, Wilhelm Gerhard Dirks, Christoph Reissfelder et al.

6. Analysis of Inflammation-Related Genes in Patients with Stanford Type A Aortic Dissection

Journal: Journal of Personalized Medicine

Date: 2023-06-13

DOI: 10.3390/jpm13060990

Contributors: Lin Li, Ziwei Zeng, Vugar Yagublu, Nuh Rahbari, Christoph Reißfelder, Michael Keese

7. Investigation of Different Methods of Intraoperative Graft Perfusion Assessment during Kidney Transplantation for the Prediction of Delayed Graft Function: A Prospective Pilot Trial

Journal: Journal of Personalized Medicine

Date: 2022-10

DOI: 10.3390/jpm12101749

Contributors: Andreas Gerken, Michael Keese, Christel Weiss, Hanna-Sophie Krücken, Katarina A. P. Pecher, Augusto Ministro, Nuh N. Rahbari, Christoph Reissfelder, Ulrich Rother, Babak Yazdani et al.

Conclusion:

Assoc. Prof. Dr. Michael Keese is a strong contender for the “Best Review Article Award.” His significant contributions to advancing stem cell research, particularly in the differentiation and regenerative potential of ABCB5+ mesenchymal stem cells, align well with the objectives of this award. His work is not only well-regarded in academic circles but also demonstrates the potential to improve clinical applications, making it highly relevant to current scientific and medical challenges.

 

Giulia Passaniti | Medicine | Best Review Article Award

Posted on by ScienceFather

Dr. Giulia Passaniti | Medicine | Best Review Article Award

Dr. Giulia Passaniti, Centro Alte Specialità e Trapianti- Policlinico G. Rodolico- San Marco, Italy

Dr. Giulia Passaniti is a highly accomplished medical professional specializing in cardiovascular imaging and structural heart interventions. She is currently pursuing an Imaging Fellowship for Structural Heart Interventions at Mount Sinai Hospital, New York (2023-2024). Dr. Passaniti has also completed advanced training in Stress, Transesophageal, and Advanced Echocardiography at the Azienda Ospedaliera Università di Padova, where she earned a Second-Level Master’s Degree with Summa Cum Laude (2022-2023).

Education:

Imaging Fellowship for Structural Heart Interventions

Institution: Mount Sinai Hospital, New York

Duration: 07/01/2023 – 06/30/2024

Stress, Transesophageal, and Advanced Echocardiography

Institution: Azienda Ospedaliera Università di Padova – Cardiovascular Disease Department

Degree: Second-Level Master’s Degree

Duration: 11/01/2022 – 09/22/2023

Honors: Graduated Summa cum laude

Cardiovascular Diseases Fellowship

Institution: Azienda Ospedaliera Universitaria Policlinico “G. Rodolico”, Catania, Italy

Duration: 01/26/2021 – 01/26/2025

Clinical Clerkship

Institution: Policlinico “G. Rodolico”, Catania, Italy

Duration: 10/01/2018 – 01/31/2019

Medical Education (Doctor of Medicine – MD)

Institution: Facoltà di Medicina e Chirurgia, Università di Catania

Duration: 10/06/2012 – 07/18/2018

Honors: Graduated Summa cum laude on 07/18/2018

Professional Profiles:

ORCID Profile

Google Scholar

Professional Experience:

Dr. Giulia Passaniti has gained extensive medical experience through various roles in Italy’s healthcare system. From February 2020 to December 2020, she served as a Medical Doctor at Centro Alte Specialità e Trapianti- Policlinico G. Rodolico- San Marco, where she contributed to specialized medical care and transplant-related services. Prior to this, from November 2019 to February 2020, she worked at Centro Multispecialistico Etneo, gaining experience in a multidisciplinary clinical setting. Additionally, she provided medical care at Guardia Medica of Aci Sant’Antonio from November 2019 to February 2020 and at Guardia Medica of Pedara from July 2019 to September 2019, where she was responsible for emergency medical assistance and primary healthcare services. Her diverse clinical background highlights her ability to adapt to different medical environments and provide high-quality patient care.

Top Notable Publications:

Role of advanced cardiovascular imaging in chemotherapy-induced cardiotoxicity
Heliyon, 2023
Contributors: MT Cannizzaro, MC Inserra, G Passaniti, A Celona, T D’Angelo, P Romeo, et al.

Pulmonary hypertension
Novel Pathogenesis and Treatments for Cardiovascular Disease, 2022
Contributors: M Mulè, G Passaniti, D Giannazzo

MR imaging of primary benign cardiac tumors in the pediatric population
Heliyon, 2023
Contributors: MC Inserra, MT Cannizzaro, G Passaniti, A Celona, A Secinaro, et al.

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique
Cardiovascular Interventions, 2024
Contributors: G Passaniti, GHL Tang, R Tanner, SK Sharma, AS Kini, S Lerakis

Do we still need intra-procedural TTE during Transcatheter aortic valve replacement? A high volume, single center experience
Cardiovascular Revascularization Medicine, 2024
Contributors: YN Granot, G Passaniti, FR Prandi, SK Sharma, A Kini, S Lerakis

Echo HALT: do we really need a cardiac CT?
The International Journal of Cardiovascular Imaging, 2024
Contributors: G Passaniti, FR Prandi, S Sharma, A Kini, S Lerakis

Fundamental Roles of Intracardiac Echocardiography and Fluoroscopy in Redo Tricuspid Transcatheter Edge-to-Edge Repair Procedure
Cardiovascular Interventions, 2024
Contributors: G Passaniti, LM Safi, F Prandi, S Ratanapo, S Lerakis, GHL Tang, et al.

IMPACT OF AORTIC VALVE CALCIFICATION SEVERITY IN PATIENTS WITH LOW-FLOW LOW-GRADIENT AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
Journal of the American College of Cardiology, 2024
Contributors: R Singh, L Chopra, D Sperling, A Dalsania, H Ueyama, FR Prandi, et al.

Imaging in a Rare Case of Neonatal Arterial Tortuosity Syndrome
Global Medical Genetics, 2023
Contributors: MC Inserra, A Di Mari, G Passaniti, MT Cannizzaro, G La Rosa, D Poli, et al.

Myocardial fibrosis in aortic stenosis: Comparison between clinical data, laboratory, echocardiography, and cardiac magnetic resonance
Journal of Cardiology and Cardiovascular Medicine, 2023
Contributors: G Tosto, G Passaniti, FA Gibiino, W Deste, A Indelicato, T Torrisi, et al.

Conclusion:

Dr. Giulia Passaniti is a highly suitable candidate for the Research for Best Review Article Award due to her expertise in cardiovascular imaging, extensive collaborations, and high-quality publications. Strengthening her focus on systematic reviews and increasing outreach efforts could further solidify her eligibility for this prestigious recognition.

Xiangyu Zhong | Medicine | Best Researcher Award

Posted on by ScienceFather

Prof. Xiangyu Zhong | Medicine | Best Researcher Award

Prof. Xiangyu Zhong, The 2nd Affiliated Hospital of Harbin Medical University, China

Professor Xiangyu Zhong is a distinguished academic and chief physician at the Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University, China. With a robust background in medicine and extensive clinical experience, his research primarily focuses on cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury.

Professional Profiles:

Scopus

Professional Experience:

Prof. Xiangyu Zhong is a distinguished academician with a robust educational background in medicine. He serves as a Professor and Chief Physician in the Department of General Surgery at the Second Affiliated Hospital of Harbin Medical University. With extensive clinical expertise, he has significantly contributed to medical research, particularly in the fields of cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury. His academic journey is complemented by 57 publications in SCI/Scopus indexed journals, with a citation index of 1172, solidifying his position as a leading researcher in his field.

Research Interests:

Prof. Zhong’s research is focused on cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work has substantially enhanced the understanding of these diseases, offering valuable insights into their pathogenesis and potential therapeutic approaches. With three ongoing research projects, his contributions continue to shape the future of clinical treatments and patient care in liver diseases. Although there are no consultancy or industry projects, Prof. Zhong’s research alone has garnered significant recognition, evidenced by his numerous publications and citation index. His contributions have directly impacted advancements in surgical techniques and liver disease management.

Contributions and Impact:

Prof. Zhong’s impactful research has led to significant advancements in understanding complex liver diseases such as cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work, which has been cited over 1,100 times, is widely recognized for providing new insights and therapeutic approaches that directly benefit patient care. The depth of his research has influenced both the scientific community and clinical practices, furthering knowledge in areas critical for the treatment of liver-related ailments. With a high citation index and numerous peer-reviewed publications, his work continues to drive innovation in liver surgery and related fields.

Publications:

Circ_0007534 Promotes Cholangiocarcinoma Stemness and Resistance to Anoikis through DDX3X-Mediated Positive Feedback Regulation of Parental Gene DDX42
Liu, S., Guan, C., Sha, X., Zhong, X., Jiang, X.
Cellular Signalling, 2024, 118, 111141

Open access

0 citations

Utilization of 3D Printing Technology in Hepatopancreatobiliary Surgery
Shi, W., Wang, J., Gao, J., Cui, Y., Zhong, X.
Journal of Zhejiang University: Science B, 2024, 25(2), pp. 123–134

Open access

1 citation

Forkhead Box O1 in Metabolic Dysfunction-Associated Fatty Liver Disease: Molecular Mechanisms and Drug Research
Sha, X., Zou, X., Liu, S., Zhong, X., Jiang, X.
Frontiers in Nutrition, 2024, 11, 1426780

Open access

1 citation

Research Progress and Applications of Epigenetic Biomarkers in Cancer
Gao, J., Shi, W., Wang, J., Zhong, X., Cui, Y.
Frontiers in Pharmacology, 2024, 15, 1308309

Open access

1 citation

Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, J., Wang, J., Guan, C., Xu, X., Zhong, X.
Journal of Cancer, 2024, 15(8), pp. 2214–2228

Open access

0 citations

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Yang, C., Dong, Q., Bao, H., Xu, Y., Zhong, X.
Frontiers in Bioscience – Landmark, 2024, 29(1), 45

Open access

0 citations

Cullin-Associated and Neddylation-Dissociated Protein 1 (CAND1) Alleviates NAFLD by Reducing Ubiquitinated Degradation of ACAA2
Huang, X., Liu, X., Li, X., Yang, B., Pan, Z.
Nature Communications, 2023, 14(1), 4620

Open access

5 citations

Retraction: The Prognostic Potential and Carcinogenesis of Long Non-Coding RNA TUG1 in Human Cholangiocarcinoma
Xu, Y., Leng, K., Li, Z., Jiang, X., Cui, Y.
Oncotarget, 2023, 14, pp. 779

Retraction

0 citations

Application of Normothermic Regional Perfusion in Controlled Donation After Cardiac Death Liver Transplant Donors
Zou, X., Huang, Z., Shi, W., Cui, Y., Zhong, X.
China Journal of General Surgery, 2023, 32(7), pp. 1087–1096

Open access

1 citation

Exosomal miRNAs in the Microenvironment of Pancreatic Cancer
Zou, X., Huang, Z., Guan, C., Xu, Y., Zhong, X.
Clinica Chimica Acta, 2023, 544, 117360

Open access

1 citation

Conclusion:

Prof. Xiangyu Zhong is undoubtedly a strong contender for the Best Researcher Award due to his extensive research contributions, leadership in collaborative efforts, and impact on medical and therapeutic advancements. While there are areas where improvement could further elevate his profile, such as increasing citations and expanding clinical research involvement, his overall academic impact, innovation, and leadership make him a deserving candidate. His work not only contributes to fundamental science but also holds significant promise for improving patient care and treatment outcomes, which is at the core of the Best Researcher Award’s mission.